Endotoxemia is common following abdominal organ transplantation and is associated with reperfusion and rejection

Journal of Organ Dysfunction

Volumn 5, Issue 4, 2009, Pages 254-260

  Hilmi, Ibtesam ^a   Kellum, John A ^a   Planinsic, Raymond ^a   Foster, Debra ^b   Abdullah, Ali ^a   Damian, Daniela ^a   Gligor, Silviu ^a   Klein, David ^c   Abu Elmagd, Kareem ^d  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b Spectral Diagnostics Inc   (Canada)

^c ST MICHAEL'S HOSPITAL   (Canada)

^d UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Cellular rejection; Endotoxemia; Liver transplantation; Reperfusion syndrome; Small bowel transplantation

Indexed keywords

ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; ENDOTOXIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; ENDOTOXEMIA; FEMALE; GRAFT REJECTION; HUMAN; INTENSIVE CARE UNIT; LIVER CLEARANCE; LIVER TRANSPLANTATION; MALE; ORGAN TRANSPLANTATION; PERIOPERATIVE PERIOD; POSTOPERATIVE INFECTION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; REPERFUSION INJURY; SEPSIS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 70450280746     PISSN: 17471060     EISSN: 17471079     Source Type: Journal    
DOI: 10.3109/17471060902859113     Document Type: Article

References (17)

1. Pillay SP,Wynter C, Lynch S,Wall D, Balderson G, Strong R. Endotoxin levels in donors and recipients during orthotopic liver transplantation. Aust N Z J Surg 1997;/67:/187-91.
2. Maring JK, Klompmaker IJ, Zwavelling JH, Van Der Meer J, Limburg PC, Slooff MJ. Endotoxin and cytokines during liver transplantation: changes in plasma levels and effects on clinical outcome. Liver Transpl 2000;/6:/480-8.
3. Abdala E, Baia C, Mies S, Massarolla OC, de Paula Cavalheir N, Baia VR, et al. Bacterial translocation during liver transplantation: a randomized trial comparing conventional with venovenous bypass vs. piggyback methods. Liver Transpl 2007;/13:/488-96.
4. Guarner C, Soriano G. Bacterial translocation and its consequences in patients with cirrhosis. Eur J Gastroenterol Hepatol 2005;/17:/27-31.
5. Van Leeuwen PA, Boermeester MA, Haudijk AP, Ferwerda CC, Cuesta MA, Meyer S, et al. Clinical significance of translocation. Gut 1994;/35(1 Suppl):/S28-34.
6. Marshall JC, Walker PM, Foster DM, Harris D, Ribeiro M, Romaschin AD, et al. Measurement of endotoxin activity in critically ill patients using whole blood neutrophil dependent chemiluminescence. Crit Care 2002;/6:/342-8.
7. Hilmi I, Horton CN, Planinsic RM, Sakai T, Nicolau-Raducu R, Damian D, et al. The impact of postreperfusion syndrome on short-term patient and liver allograft outcome in patients undergoing orthotopic liver transplantation. Liver Transpl 2008;/14:/504-8.
8. Bohlen HG. Integration of intestinal structure, function and microvasculature regulation. Microcirculation 1998;/5:/27-37.
9. Lev B, Bollaert PE, Charpentier C, Nace L, Audibert G, Bauer P, et al. Comparison of norepinephrine and dobutamine to epinephrine for hemodynamics, lactate metabolism and gastric tonometric variables in septic shock: prospective, randomized study. Intensive Care Med 1997;/23:/282-7.
10. Zhang H, De Jongh R, De Backer D, Cherkaoui S, Viray B, Vincent JL. Effects of alpha- and beta-adrenergic stimulation on hepatosplanchnic perfusion and oxygen extraction in endotoxic shock. Crit Care Med 2001;/29:/581-8. (Pubitemid 32225301)
11. Rancel-Frausto MS, Pittet D, Costigan M, Hwang T, Davis CS, Wenzel RP. The natural history of the systemic inflammatory response (SIRS). A prospective study. JAMA 1995;/ 273:/117-23.
12. Halpern MD, Holubec H, Domínguez JA, Meza YG, Williams CS, Ruth MC, et al. Hepatic inflammatory mediators contribute to intestinal damage in necrotizing enterocolitis. Am J Physiol Gastrointest Liver Physiol 2003;/ 284:/G695-702.
13. Arranow JS, Fink MP. Determinants of intestinal barrier failure in critical illness. Br J Anaesth 1996;/77:/71-81.
14. Marshall JC, Foster DM, Vincent JL, Cook DJ, Cohen J, Dellinger RP, et al. Diagnostic and prognostic implications of endotoxemia in critical illness: results of the MEDIC study. J Infect Dis 2004;/190:/527-34.
15. Nishimura A, Hakamada K, Narumi S, Totsuka E, Toyoki Y, Ishizawa Y, et al. Intraoperative blood lactate level as an early predictor of initial graft function in human living donor liver transplantation. Transpl Proc 2004;/36:/2246-8.
16. Ruberto F, Pugliese F, D'Alio A, Martelli S, Bruno K, Marcellino V, et al. Clinical effects of use of polymyxin-B fixed on fibers in liver transplant patients with severe sepsis or septic shock. Transpl Proc 2007;/39:/1953-5.
17. Ruberto F, Pugliese F, D'Alio A, Martelli S, Bruno K, Marcellino V, et al. Clinical effects of direct hemoperfusion using a polymyxin-B immobilized column in solid organ transplant patients with signs of severe sepsis or septic shock. A pilot study. Int J Artif Organs 2007;/30:/915-22.